Updated HIV Drug Pricelist

UNICEF Supply web site (http://www.supply.unicef.dk)
2002-04-29

95% of all people infected with HIV/AIDS live in the developing world. The following UNICEF report, recently announced on E-DRUG, may help address this reality by providing market data on sources and comparative drug prices for governments.

�Of the more than 36 million people living with HIV/AIDS today, over 95% live in developing countries. Many of them do not have access to even the basic drugs needed to treat HIV-related infections and other conditions. In many of the poorest countries, essential drugs including painkillers, antibiotics, and tuberculosis drugs are in desperately short supply.

The high price of many AIDS drugs � especially antiretroviral drugs � is one of the main barriers to their availability in developing countries. However, even where cheaper alternatives exist, many decision-makers do not have the information they need to identify manufacturers which can supply these drugs. They require easier access to comparative prices.

This report sets out to provide that data -- market information that can be used to help government procurement agencies make informed decisions on the source of drugs and serve as the basis for negotiating affordable prices. The aim is to help increase access to drugs for people in developing countries living with HIV/AIDS. The report is based on a survey of over 200 pharmaceutical manufacturers in 40 countries world wide. It
is the latest in a series of reports launched in 2000 and issued twice a year by UNICEF, UNAIDS, WHO and MSF.�

The full (36-page) report is downloadable as a PDF file from:
http://www.supply.unicef.dk/insideSD/HIVMay2001.pdf